Case Study

Monsanto's genetically modified organisms: The battle for hearts and shopping aisles

18 pages
August 2000
Reference: IMD-2-0086

Monsanto, an American company founded in 1901 originally specialized in chemicals. In 1995 the firm reoriented its strategy around more lucrative, but unproven, fields such as agricultural biotechnology. The case describes how in the space of a few years, Monsanto becomes market leader of bio-engineered cereal crops–commonly known as genetically modified organisms (GMOs)–but is accused of applying an unsafe gene technology and trying to dominate world food supplies. The firm is caught up in a worldwide controversy. The case documents how Monsanto was implicated in a trade dispute and reacted poorly to public criticism, particularly in its lack of dialogue with stakeholders. Overall, the case illustrates how public pressure obliged Monsanto to stop following a promising strategy.

Keywords
Environment, Agricultural Biotechnology, Pharmaceuticals, Corporate Sustainability Management
Settings
Europe, United States of America
1995-1999
Type
Published Sources
Copyright
© 2001
Available Languages
English
Related material
Teaching note
Case clearing houses
IMD case studies are distributed through case clearing houses. In order to browse the collection and purchase copies please visit the links below.

The Case Centre

Cranfield University

Wharley End Beds MK43 0JR, UK
Tel +44 (0)1234 750903
Email [email protected]

Harvard Business School Publishing

60 Harvard Way, Boston MA 02163, USA
Tel (800) 545-7685 Tel (617)-783-7600
Fax (617) 783-7666
Email [email protected]

Asia Pacific Case Center

NUCB Business School

1-3-1 Nishiki Naka
Nagoya Aichi, Japan 460-0003
Tel +81 52 20 38 111
Email [email protected]

Contact

Research Information & Knowledge Hub for additional information on IMD publications

Looking for something specific?
IMD's faculty and research teams publish articles, case studies, books and reports on a wide range of topics